The U.S. Attorney's Office is taking a major Boston healthcare provider to court, accusing Steward St. Elizabeth’s Medical Center, Steward Medical Group, and parent company Steward Health Care System of gaming the Medicare system for profit. The federal lawsuit alleges that these institutions have been deeply enmeshed in illegal billing practices, breaching the Stark Law by submitting Medicare claims tainted by improper financial incentives with physicians.
According to a statement released on the U.S. Attorney's Office's website, the heart of the case revolves around allegations that the defendants egregiously chose to quickly increase their cardiac surgery numbers, and thus profits, at the cost of possibly upending the very integrity of medical decision-making. In what seems to be a blatant disregard for legal and ethical standards, the government claims that from January 2013 through March 2022, the defendants paid a cardiac surgeon in a manner that scandalously considered the volume of his referrals to their own facility.
The alleged scheme between Steward Health Care and Dr. Agnihotri, recruited in 2012 to boost the number of surgeries, involved compensation that not only exceeded fair market value but also included incentives illegal under Stark Law provisions. Acting U.S. Attorney Joshua S. Levy emphasized the magnitude of the violations, stating, "The government’s complaint today alleges that in its drive to increase cardiac surgeries at SEMC, the defendants entered into improper compensation arrangements with a cardiac surgeon, and knowingly submitted false claims to Medicare." This accusation paints a broad stroke of corruption, potentially impacting numerous Medicare beneficiaries and costing the federal program tens of millions of dollars in false claims.
In essence, the government asserts that SMG baited Dr. Agnihotri with approximately $4.9 million in incentive compensation directly linked to the number of surgeries referred—an arrangement strictly prohibited under current law. Roberto Coviello of the U.S. Department of Health and Human Services, Office of Inspector General, warned of the perils such compacts pose: "Improper financial arrangements between hospitals and physicians can compromise medical judgement and threaten the integrity of the Medicare program." This sentiment was echoed by Jodi Cohen of the FBI, reaffirming a dedicated stance to rigorously investigate deals suspected to critically undermine impartial medical judgment.
The gravity of the lawsuit is underscored further by its origins; a whistleblower's courage under the qui tam provisions of the False Claims Act sparked this entire investigation. Though the allegations put forth by the United States are pending final legal adjudication, with no official verdict on liability yet, the implications reverberate beyond the courtroom as a sobering reminder of the potential weaknesses in our healthcare system's safeguards against greed.
